Incidence of Bleeding, Thrombotic Complications After CAR-T Therapy
Researchers sought to determine the incidence of bleeding and thrombotic events in patients receiving CAR-T therapy.
Acute Lymphoblastic Leukemia
TCR-haplo-HSCT With ATG May Yield Response in Patients With Relapsed/Refractory BCR-ALL
Researchers sought to determine whether T cell replete HLA haploidentical hematopoietic stem cell transplantation with low-dose anti-thymocyte globulin would improve outcomes in patients with BCP-ALL.
Expression of miRNA Family 181 Linked With Risk of GVHD in Patients With Acute Lymphoblastic Leukemia
Researchers sought to determine risks associated with miRNA-181a in patients with ALL.
Low-Dose Inotuzumab Ozogamicin May Be Safe and Effective in Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia
Researchers sought to determine whether a low dose of inotuzumab ozogamicin would be safe and effective in patients with relapsed/refractory ALL.
Racial/Ethnic and Socioeconomic Disparities in Outcomes Among Children With Acute Lymphoblastic Leukemia
Researchers sought to determine whether there are disparities by race/ethnicity and socioeconomic status in survival outcomes of children with ALL.
Long-Term Effects of Pediatric Acute Lymphoblastic Leukemia
Researchers sought to determine the long-term adverse events that occur as a result of pediatric ALL.
Genomic Markers May Predict Clinical Outcomes in Patients With B-Cell Acute Lymphoblastic Leukemia
Researchers sought to determine whether genomic evaluation in patients with BCR-ABL1 negative B-ALL may improve risk assessments.
Study Identifies Factors Linked With CNS Relapse in Pediatric Patients With Acute Lymphoblastic Leukemia
Researchers sought to determine the risk factors of CNS relapse in pediatric patients with ALL.
Poor Prognosis Seen for Patients With B-Cell Acute Lymphoblastic Leukemia Progression After CAR-T Therapy
Researchers sought to determine whether patients with B-ALL who progress after CAR-T therapy would have a poor prognosis.
No Characteristic Differences Identified Between Late and Very Late Relapse Acute Lymphoblastic Leukemia
Researchers sought to determine the characteristic differences between LR and VLR in patients with ALL.
- Loading...
Loading...
Loading... 
Loading...